NCT03893357View on ClinicalTrials.gov

Prevalence of Antiphospholipid Antibodies in the Hemodialysis Patients Population Within the CHU Brugmann Hospital

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

July 25, 2019

Study Completion Date

July 25, 2019

Conditions
Antiphospholipid Syndrome
Interventions
OTHER

Data extraction from medical files

Retrospective data extraction from the medical files

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT03893357 - Prevalence of Antiphospholipid Antibodies in the Hemodialysis Patients Population Within the CHU Brugmann Hospital | Biotech Hunter | Biotech Hunter